JDOC vs. JMOM

Last updated Jun 4, 2026

JDOC (Jpmorgan Healthcare Leaders ETF) and JMOM (JPMorgan U.S. Momentum Factor ETF) are both exchange-traded funds - JDOC is a Health & Biotech Equities fund actively managed by JPMorgan, while JMOM is a Momentum fund tracking the JP Morgan US Momentum Factor Index. JDOC is actively managed, while JMOM is passively managed. Over the past year, JDOC returned 12.36% vs 36.77% for JMOM. A 0.52 correlation means they provide meaningful diversification when combined. JDOC charges 0.65%/yr vs 0.12%/yr for JMOM.

Performance

JDOC vs. JMOM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Jpmorgan Healthcare Leaders ETF (JDOC) and JPMorgan U.S. Momentum Factor ETF (JMOM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, JDOC achieves a -4.49% return, which is significantly lower than JMOM's 22.79% return.

JDOC

• 1D: 0.50%
• 1M: 0.16%
• YTD: -4.49%
• 6M: -4.39%
• 1Y: 12.36%
• 3Y*: —
• 5Y*: —
• 10Y*: —

JMOM

• 1D: -0.17%
• 1M: 9.35%
• YTD: 22.79%
• 6M: 22.27%
• 1Y: 36.77%
• 3Y*: 28.37%
• 5Y*: 16.28%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

JDOC vs. JMOM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
JDOC Jpmorgan Healthcare Leaders ETF	-4.49%	15.36%	-1.04%	10.71%
JMOM JPMorgan U.S. Momentum Factor ETF	22.79%	18.02%	28.47%	11.78%

Correlation

The correlation between JDOC and JMOM is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.44
Correlation (All Time) Calculated using the full available price history since Nov 3, 2023	0.52

The correlation between JDOC and JMOM has been stable across timeframes, ranging from 0.44 to 0.52 - a consistent structural relationship.

JDOC vs. JMOM - Sectors Allocation Comparison

Sectors	JDOC	JMOM
Healthcare	100.0%	8.7%
Basic Materials	-	1.3%
Communication Services	-	8.3%
Consumer Cyclical	-	6.9%
Consumer Defensive	-	5.7%
Energy	-	3.8%
Financial Services	-	9.6%
Industrials	-	12.8%
Real Estate	-	2.5%
Technology	-	38.1%
Utilities	-	2.3%

Return for Risk

JDOC vs. JMOM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JDOC

JDOC Risk / Return Rank: 26
JDOC Sharpe Ratio Rank: 25
JDOC Sortino Ratio Rank: 26
JDOC Omega Ratio Rank: 24
JDOC Calmar Ratio Rank: 27
JDOC Martin Ratio Rank: 25

JMOM

JMOM Risk / Return Rank: 81
JMOM Sharpe Ratio Rank: 78
JMOM Sortino Ratio Rank: 77
JMOM Omega Ratio Rank: 74
JMOM Calmar Ratio Rank: 85
JMOM Martin Ratio Rank: 91

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JDOC vs. JMOM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Jpmorgan Healthcare Leaders ETF (JDOC) and JPMorgan U.S. Momentum Factor ETF (JMOM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	JDOC	JMOM	Difference
Sharpe ratio: Return per unit of total volatility	0.88	2.58	-1.70
Sortino ratio: Return per unit of downside risk	1.38	3.54	-2.16
Omega ratio: Gain probability vs. loss probability	1.16	1.45	-0.29
Calmar ratio: Return relative to maximum drawdown	1.28	4.69	-3.41
Martin ratio: Return relative to average drawdown	3.34	22.24	-18.90
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

JDOC vs. JMOM - Sharpe Ratio Comparison

The current JDOC Sharpe Ratio is 0.88, which is lower than the JMOM Sharpe Ratio of 2.58. The chart below compares the historical Sharpe Ratios of JDOC and JMOM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	JDOC	JMOM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.88	2.58	-1.70
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.88	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.53	0.82	-0.29

Drawdowns

JDOC vs. JMOM - Drawdown Comparison

The maximum JDOC drawdown since its inception was -20.87%, smaller than the maximum JMOM drawdown of -34.31%. Use the drawdown chart below to compare losses from any high point for JDOC and JMOM.

Drawdown Indicators

	JDOC	JMOM	Difference
Max Drawdown Largest peak-to-trough decline	-20.87%	-34.31%	+13.44%
Max Drawdown (1Y) Largest decline over 1 year	-9.68%	-7.87%	-1.81%
Max Drawdown (3Y) Largest decline over 3 years	—	-19.51%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-28.26%	—
Current Drawdown Current decline from peak	-7.47%	-0.17%	-7.30%
Average Drawdown Average peak-to-trough decline	-6.98%	-6.32%	-0.66%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.71%	1.66%	+2.05%

Volatility

JDOC vs. JMOM - Volatility Comparison

The current volatility for Jpmorgan Healthcare Leaders ETF (JDOC) is 3.97%, while JPMorgan U.S. Momentum Factor ETF (JMOM) has a volatility of 4.62%. This indicates that JDOC experiences smaller price fluctuations and is considered to be less risky than JMOM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	JDOC	JMOM	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.97%	4.62%	-0.65%
Volatility (6M) Calculated over the trailing 6-month period	9.97%	11.55%	-1.58%
Volatility (1Y) Calculated over the trailing 1-year period	14.08%	14.32%	-0.24%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	14.32%	18.65%	-4.33%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	14.32%	20.13%	-5.81%

JDOC vs. JMOM - Expense Ratio Comparison

JDOC has a 0.65% expense ratio, which is higher than JMOM's 0.12% expense ratio.

Dividends

JDOC vs. JMOM - Dividend Comparison

JDOC's dividend yield for the trailing twelve months is around 0.93%, more than JMOM's 0.71% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
JDOC Jpmorgan Healthcare Leaders ETF	0.93%	0.89%	5.57%	0.15%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
JMOM JPMorgan U.S. Momentum Factor ETF	0.71%	0.86%	0.75%	1.21%	1.39%	0.64%	0.85%	1.11%	1.38%	0.29%

Frequently Asked Questions

Can I hold both JDOC and JMOM in my portfolio?

JDOC and JMOM have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, JDOC or JMOM?

JMOM has higher volatility (4.62%) compared to JDOC (3.97%). In terms of maximum drawdown, JDOC dropped -20.87% vs JMOM's -34.31%.

Which ETF is better, JDOC or JMOM?

On 1-year performance, JMOM leads with 36.77% vs 12.36% for JDOC. On fees, JMOM is cheaper at 0.12% per year. On volatility, JDOC has been the lower-risk option at 3.97%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, JDOC or JMOM?

Over the 1-year period, JMOM has performed better with a 36.77% return vs 12.36%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, JDOC or JMOM?

JMOM is cheaper with a 0.12% expense ratio, compared with 0.65% for JDOC.

Which ETF pays a higher dividend yield, JDOC or JMOM?

JDOC has the higher dividend yield at 0.93%, compared with 0.71% for JMOM.

What is the main difference between JDOC and JMOM?

JDOC is categorized as Health & Biotech Equities, while JMOM is Momentum. Their fees differ too: 0.65% for JDOC and 0.12% for JMOM.

Which has better risk-adjusted returns?

JMOM currently has the higher Sharpe Ratio (2.58 vs 0.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.